RAPT Therapeutics jumps on mid-stage data for urticaria candidate
Source: SeekingAlpha
2025-10-20 11:03:00 ET
More on RAPT Therapeutics
- Seeking Alpha’s Quant Rating on RAPT Therapeutics
- Historical earnings data for RAPT Therapeutics
- Financial information for RAPT Therapeutics
Read the full article on Seeking Alpha
For further details see:
RAPT Therapeutics jumps on mid-stage data for urticaria candidate
Novartis AG
NASDAQ: NVS
NVS Trading
0.77% G/L:
$155.22 Last:
137,402 Volume:
$154.54 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
February 22, 2026 03:07:00 pm
Novartis: This Big Pharma Giant Could Be a Sleep?at?Night Core Holding for Decades
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
